珍宝岛药业全力推动中药饮片供给体系高质量发展

Core Viewpoint - Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.'s subsidiary, Anhui Jiuzhou Fangyuan Pharmaceutical Co., Ltd., is advancing the standardization, scaling, and efficiency of traditional Chinese medicine (TCM) decoction pieces supply system through collaboration with national partners [1][2]. Group 1 - Jiuzhou Fangyuan has achieved the highest national ranking in terms of variety diversity, regional coverage, and total selection in the national TCM decoction piece alliance procurement, covering 2,448 specifications across provinces [1]. - The company has an annual supply capacity of 15,000 tons and an intelligent supply chain system that addresses the core delivery challenges of centralized procurement [1]. - The company is integrating the entire industry chain by establishing its own GAP planting bases, local medicinal material warehouses, and fresh processing bases, ensuring a traceable system from planting to processing [1]. Group 2 - Jiuzhou Fangyuan is developing an intelligent production base and is a leader in national storage and transportation systems, supporting stable delivery of large-scale procurement orders [1]. - The company provides clinical value-added services by forming a professional academic team to offer medication training and clinical research support to medical institutions [1]. - The company is deepening its supply chain layout in various local medicinal material production areas and building an efficient network for "initial processing at the production site - regional distribution - national delivery" [1]. Group 3 - The chairman of Zhenbaodao Pharmaceutical emphasizes the importance of resource openness, broad cooperation, and continuous innovation across planting, production, and clinical stages to achieve industry win-win outcomes [2]. - Jiuzhou Fangyuan plans to collaborate with pharmaceutical peers and local medicinal material suppliers to promote high-quality TCM decoction pieces to a wider market [2].